TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated November 28, 1975